Adeoye Olukotun - Jun 10, 2024 Form 4 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)

Role
Director
Signature
/s/ Jessica Morris, Attorney-in-Fact
Stock symbol
TNXP
Transactions as of
Jun 10, 2024
Transactions value $
-$2
Form type
4
Date filed
2/28/2025, 05:31 PM
Previous filing
May 24, 2024
Next filing
Dec 20, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNXP Common Stock, par value $0.001 Other -$2 -0.812 -100.25% $1.91 0 Jun 10, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Involuntary sale of fractional shares following a reverse stock split of the Issuer's common stock.